Published in PLoS One on July 27, 2012
Selection of 2'-deoxy-2'-fluoroarabinonucleotide (FANA) aptamers that bind HIV-1 reverse transcriptase with picomolar affinity. Nucleic Acids Res (2015) 0.82
Recent findings on the mechanisms involved in tenofovir resistance. Antivir Chem Chemother (2014) 0.75
Telomerase catalytic subunit homologs from fission yeast and human. Science (1997) 12.35
Origin and evolution of retroelements based upon their reverse transcriptase sequences. EMBO J (1990) 9.93
Origins and evolutionary relationships of retroviruses. Q Rev Biol (1989) 6.82
HIV-1 genome nuclear import is mediated by a central DNA flap. Cell (2000) 5.87
Mechanism of DNA strand transfer reactions catalyzed by HIV-1 reverse transcriptase. Science (1992) 3.81
Dynamic binding orientations direct activity of HIV reverse transcriptase. Nature (2008) 2.94
Ty3, a yeast retrotransposon associated with tRNA genes, has homology to animal retroviruses. Mol Cell Biol (1988) 2.81
Point mutations in conserved amino acid residues within the C-terminal domain of HIV-1 reverse transcriptase specifically repress RNase H function. FEBS Lett (1989) 2.20
Kinetic mechanism of the DNA-dependent DNA polymerase activity of human immunodeficiency virus reverse transcriptase. J Biol Chem (1993) 1.98
Insights into DNA polymerization mechanisms from structure and function analysis of HIV-1 reverse transcriptase. Biochemistry (1995) 1.93
Evolution of retroposons by acquisition or deletion of retrovirus-like genes. Mol Biol Evol (1991) 1.75
Human immunodeficiency virus reverse transcriptase: steady-state and pre-steady-state kinetics of nucleotide incorporation. Biochemistry (1992) 1.69
Synthesis of plus strands of retroviral DNA in cells infected with avian sarcoma virus and mouse mammary tumor virus. J Virol (1981) 1.67
Sequence and structural determinants required for priming of plus-strand DNA synthesis by the human immunodeficiency virus type 1 polypurine tract. J Virol (1996) 1.53
'Binding, bending and bonding': polypurine tract-primed initiation of plus-strand DNA synthesis in human immunodeficiency virus. Int J Biochem Cell Biol (2004) 1.46
Pre-existing distortions in nucleic acid structure aid polypurine tract selection by HIV-1 reverse transcriptase. J Biol Chem (2002) 1.45
Human immunodeficiency virus type 1 preintegration complexes containing discontinuous plus strands are competent to integrate in vitro. J Virol (1995) 1.43
High-affinity ssDNA inhibitors of the reverse transcriptase of type 1 human immunodeficiency virus. Biochemistry (1995) 1.34
The sequence features important for plus strand priming by human immunodeficiency virus type 1 reverse transcriptase. J Biol Chem (1993) 1.26
Parameters that influence the binding of human immunodeficiency virus reverse transcriptase to nucleic acid structures. Biochemistry (1993) 1.24
Modified HIV-1 based lentiviral vectors have an effect on viral transduction efficiency and gene expression in vitro and in vivo. Mol Ther (2001) 1.18
Mutations in the ribonuclease H active site of HIV-RT reveal a role for this site in stabilizing enzyme-primer-template binding. Biochemistry (2002) 1.15
Effects of mutations in the G tract of the human immunodeficiency virus type 1 polypurine tract on virus replication and RNase H cleavage. J Virol (2004) 1.06
Selection of optimal polypurine tract region sequences during Moloney murine leukemia virus replication. J Virol (2000) 1.04
The orientation of binding of human immunodeficiency virus reverse transcriptase on nucleic acid hybrids. Nucleic Acids Res (1995) 1.02
Compensatory role of human immunodeficiency virus central polypurine tract sequence in kinetically disrupted reverse transcription. J Virol (2008) 1.00
Novel bimodular DNA aptamers with guanosine quadruplexes inhibit phylogenetically diverse HIV-1 reverse transcriptases. Nucleic Acids Res (2008) 1.00
The evolving world of protein-G-quadruplex recognition: a medicinal chemist's perspective. Biochimie (2011) 0.99
Control of initiation of viral plus strand DNA synthesis by HIV reverse transcriptase. J Biol Chem (1998) 0.99
Polypurine tract primer generation and utilization by Moloney murine leukemia virus reverse transcriptase. J Biol Chem (1999) 0.98
RNA degradation and primer selection by Moloney murine leukemia virus reverse transcriptase contribute to the accuracy of plus strand initiation. J Biol Chem (2000) 0.97
Physical mapping of HIV reverse transcriptase to the 5' end of RNA primers. J Biol Chem (2001) 0.95
Interaction of p55 reverse transcriptase from the Saccharomyces cerevisiae retrotransposon Ty3 with conformationally distinct nucleic acid duplexes. J Biol Chem (2000) 0.95
SHAMS: combining chemical modification of RNA with mass spectrometry to examine polypurine tract-containing RNA/DNA hybrids. RNA (2009) 0.95
Wild-type and central DNA flap defective HIV-1 lentiviral vector genomes: intracellular visualization at ultrastructural resolution levels. Retrovirology (2006) 0.94
HIV-1 reverse transcriptase interaction with model RNA-DNA duplexes. Anal Biochem (2001) 0.92
Staying straight with A-tracts: a DNA analog of the HIV-1 polypurine tract. J Mol Biol (2003) 0.92
Discontinuous plus-strand DNA synthesis in human immunodeficiency virus type 1-infected cells and in a partially reconstituted cell-free system. J Virol (1997) 0.92
Selection of primer-template sequences that bind human immunodeficiency virus reverse transcriptase with high affinity. Nucleic Acids Res (2006) 0.91
Alternate polypurine tracts affect rous sarcoma virus integration in vivo. J Virol (2006) 0.89
Fidelity of plus-strand priming requires the nucleic acid chaperone activity of HIV-1 nucleocapsid protein. Nucleic Acids Res (2009) 0.86
Novel aptamer inhibitors of human immunodeficiency virus reverse transcriptase. Oligonucleotides (2008) 0.86
A new role for HIV nucleocapsid protein in modulating the specificity of plus strand priming. Virology (2008) 0.83
In vitro analysis of the effects of mutations in the G-tract of the human immunodeficiency virus type 1 polypurine tract on RNase H cleavage specificity. Virology (2006) 0.82
Probing anomalous structural features in polypurine tract-containing RNA-DNA hybrids with neomycin B. Biochemistry (2009) 0.82
Examining Ty3 polypurine tract structure and function by nucleoside analog interference. J Biol Chem (2005) 0.81
Global transcription in pluripotent embryonic stem cells. Cell Stem Cell (2008) 5.81
Dynamic binding orientations direct activity of HIV reverse transcriptase. Nature (2008) 2.94
Slide into action: dynamic shuttling of HIV reverse transcriptase on nucleic acid substrates. Science (2008) 2.78
A fluorescence-based high-throughput screening assay for inhibitors of human immunodeficiency virus-1 reverse transcriptase-associated ribonuclease H activity. Anal Biochem (2003) 1.87
Selective inhibition of HIV-1 reverse transcriptase-associated ribonuclease H activity by hydroxylated tropolones. Nucleic Acids Res (2005) 1.75
Altering the RNase H primer grip of human immunodeficiency virus reverse transcriptase modifies cleavage specificity. Biochemistry (2002) 1.64
A cis-acting element in retroviral genomic RNA links Gag-Pol ribosomal frameshifting to selective viral RNA encapsidation. Cell Host Microbe (2013) 1.56
Multimode, cooperative mechanism of action of allosteric HIV-1 integrase inhibitors. J Biol Chem (2012) 1.55
'Binding, bending and bonding': polypurine tract-primed initiation of plus-strand DNA synthesis in human immunodeficiency virus. Int J Biochem Cell Biol (2004) 1.46
Pre-existing distortions in nucleic acid structure aid polypurine tract selection by HIV-1 reverse transcriptase. J Biol Chem (2002) 1.45
Using pyrrolo-deoxycytosine to probe RNA/DNA hybrids containing the human immunodeficiency virus type-1 3' polypurine tract. Nucleic Acids Res (2004) 1.39
Identification of specific HIV-1 reverse transcriptase contacts to the viral RNA:tRNA complex by mass spectrometry and a primary amine selective reagent. Proc Natl Acad Sci U S A (2002) 1.26
An unusual topological structure of the HIV-1 Rev response element. Cell (2013) 1.26
Synthesis, activity, and structural analysis of novel α-hydroxytropolone inhibitors of human immunodeficiency virus reverse transcriptase-associated ribonuclease H. J Med Chem (2011) 1.24
Resistance to RevM10 inhibition reflects a conformational switch in the HIV-1 Rev response element. Proc Natl Acad Sci U S A (2008) 1.22
Dissecting APOBEC3G substrate specificity by nucleoside analog interference. J Biol Chem (2009) 1.17
Initiation complex dynamics direct the transitions between distinct phases of early HIV reverse transcription. Nat Struct Mol Biol (2010) 1.15
Mutations in the ribonuclease H active site of HIV-RT reveal a role for this site in stabilizing enzyme-primer-template binding. Biochemistry (2002) 1.15
Identification of an inhibitor-binding site to HIV-1 integrase with affinity acetylation and mass spectrometry. Proc Natl Acad Sci U S A (2004) 1.13
Multiple sources of contamination in samples from patients reported to have XMRV infection. PLoS One (2012) 1.08
Role of the Reverse Transcriptase, Nucleocapsid Protein, and Template Structure in the Two-step Transfer Mechanism in Retroviral Recombination. J Biol Chem (2003) 1.07
Mutations M184V and Y115F in HIV-1 reverse transcriptase discriminate against "nucleotide-competing reverse transcriptase inhibitors". J Biol Chem (2008) 1.06
The RNA transport element of the murine musD retrotransposon requires long-range intramolecular interactions for function. J Biol Chem (2010) 1.04
Differing roles of the N- and C-terminal zinc fingers in human immunodeficiency virus nucleocapsid protein-enhanced nucleic acid annealing. J Biol Chem (2003) 1.04
Identifying and characterizing a functional HIV-1 reverse transcriptase-binding site on integrase. J Biol Chem (2009) 1.03
Structure-activity analysis of vinylogous urea inhibitors of human immunodeficiency virus-encoded ribonuclease H. Antimicrob Agents Chemother (2010) 1.03
Correlating SHAPE signatures with three-dimensional RNA structures. RNA (2011) 1.03
A ribose sugar conformational switch in the LTR-retrotransposon Ty3 polypurine tract-containing RNA/DNA hybrid. J Am Chem Soc (2005) 0.98
Ty3 integrase is required for initiation of reverse transcription. J Virol (2002) 0.98
The xenotropic murine leukemia virus-related retrovirus debate continues at first international workshop. Retrovirology (2010) 0.98
High-resolution NMR analysis of the conformations of native and base analog substituted retroviral and LTR-retrotransposon PPT primers. Chem Biol (2008) 0.96
In-gel probing of individual RNA conformers within a mixed population reveals a dimerization structural switch in the HIV-1 leader. Nucleic Acids Res (2013) 0.96
Exploring Ty1 retrotransposon RNA structure within virus-like particles. Nucleic Acids Res (2012) 0.95
A dimeric lactone from Ardisia japonica with inhibitory activity for HIV-1 and HIV-2 ribonuclease H. J Nat Prod (2007) 0.95
Reverse transcriptase in motion: conformational dynamics of enzyme-substrate interactions. Biochim Biophys Acta (2009) 0.95
Uncovering the complexities of retroviral ribonuclease H reveals its potential as a therapeutic target. AIDS Rev (2003) 0.95
SHAMS: combining chemical modification of RNA with mass spectrometry to examine polypurine tract-containing RNA/DNA hybrids. RNA (2009) 0.95
Direct and indirect contributions of RNA secondary structure elements to the initiation of HIV-1 reverse transcription. J Biol Chem (2002) 0.94
Hydrolysis of RNA/DNA hybrids containing nonpolar pyrimidine isosteres defines regions essential for HIV type 1 polypurine tract selection. Proc Natl Acad Sci U S A (2003) 0.94
Structural probing of the HIV-1 polypurine tract RNA:DNA hybrid using classic nucleic acid ligands. Nucleic Acids Res (2008) 0.94
Mass spectrometric analysis of the HIV-1 integrase-pyridoxal 5'-phosphate complex reveals a new binding site for a nucleotide inhibitor. J Biol Chem (2004) 0.94
Mutagenesis of human immunodeficiency virus reverse transcriptase p51 subunit defines residues contributing to vinylogous urea inhibition of ribonuclease H activity. J Biol Chem (2011) 0.94
Nonpolar thymine isosteres in the Ty3 polypurine tract DNA template modulate processing and provide a model for its recognition by Ty3 reverse transcriptase. J Biol Chem (2003) 0.94
SHAPE analysis of the FIV Leader RNA reveals a structural switch potentially controlling viral packaging and genome dimerization. Nucleic Acids Res (2011) 0.93
Functional interactions of nucleocapsid protein of feline immunodeficiency virus and cellular prion protein with the viral RNA. J Mol Biol (2002) 0.93
Examining the role of the HIV-1 reverse transcriptase p51 subunit in positioning and hydrolysis of RNA/DNA hybrids. J Biol Chem (2013) 0.92
Human immunodeficiency virus type 2 reverse transcriptase activity in model systems that mimic steps in reverse transcription. J Virol (2003) 0.92
Nucleotide excision repair and template-independent addition by HIV-1 reverse transcriptase in the presence of nucleocapsid protein. J Biol Chem (2006) 0.91
Mutating conserved residues in the ribonuclease H domain of Ty3 reverse transcriptase affects specialized cleavage events. J Biol Chem (2002) 0.91
An HIV RNase H inhibitory 1,3,4,5-tetragalloylapiitol from the African plant Hylodendron gabunensis. J Nat Prod (2007) 0.91
Structure/function mapping of amino acids in the N-terminal zinc finger of the human immunodeficiency virus type 1 nucleocapsid protein: residues responsible for nucleic acid helix destabilizing activity. Biochemistry (2006) 0.90
Evidence for the differential effects of nucleocapsid protein on strand transfer in various regions of the HIV genome. J Biol Chem (2003) 0.89
Mechanism of HIV reverse transcriptase inhibition by zinc: formation of a highly stable enzyme-(primer-template) complex with profoundly diminished catalytic activity. J Biol Chem (2011) 0.89
Structural analysis of monomeric retroviral reverse transcriptase in complex with an RNA/DNA hybrid. Nucleic Acids Res (2013) 0.89
Purine analog substitution of the HIV-1 polypurine tract primer defines regions controlling initiation of plus-strand DNA synthesis. Nucleic Acids Res (2006) 0.89
Active site and allosteric inhibitors of the ribonuclease H activity of HIV reverse transcriptase. Future Med Chem (2013) 0.88
A capillary electrophoretic assay for ribonuclease H activity. Anal Biochem (2004) 0.88
Structural complexity of Dengue virus untranslated regions: cis-acting RNA motifs and pseudoknot interactions modulating functionality of the viral genome. Nucleic Acids Res (2013) 0.88
Examining interactions of HIV-1 reverse transcriptase with single-stranded template nucleotides by nucleoside analog interference. J Biol Chem (2006) 0.88
XMRV accelerates cellular proliferation, transformational activity, and invasiveness of prostate cancer cells by downregulating p27(Kip1). Prostate (2011) 0.87
Attenuation of DNA replication by HIV-1 reverse transcriptase near the central termination sequence. Biochemistry (2005) 0.86
Two modes of HIV-1 polypurine tract cleavage are affected by introducing locked nucleic acid analogs into the (-) DNA template. J Biol Chem (2004) 0.86
Tighter binding of HIV reverse transcriptase to RNA-DNA versus DNA-DNA results mostly from interactions in the polymerase domain and requires just a small stretch of RNA-DNA. Biochemistry (2006) 0.85
Examining the ribonuclease H primer grip of HIV-1 reverse transcriptase by charge neutralization of RNA/DNA hybrids. Nucleic Acids Res (2008) 0.85
HIV-1 transmission by dendritic cell-specific ICAM-3-grabbing nonintegrin (DC-SIGN) is regulated by determinants in the carbohydrate recognition domain that are absent in liver/lymph node-SIGN (L-SIGN). J Biol Chem (2009) 0.85
Analysis of HIV-1 replication block due to substitutions at F61 residue of reverse transcriptase reveals additional defects involving the RNase H function. Nucleic Acids Res (2006) 0.84
Investigating HIV-1 polypurine tract geometry via targeted insertion of abasic lesions in the (-)-DNA template and (+)-RNA primer. J Biol Chem (2005) 0.84
Mechanistic analysis of pause site-dependent and -independent recombinogenic strand transfer from structurally diverse regions of the HIV genome. J Biol Chem (2004) 0.84
A primer-free method that selects high-affinity single-stranded DNA aptamers using thermostable RNA ligase. Anal Biochem (2011) 0.83
Analysis of mutations made during active synthesis or extension of mismatched substrates further define the mechanism of HIV-RT mutagenesis. Biochemistry (2003) 0.83
A new role for HIV nucleocapsid protein in modulating the specificity of plus strand priming. Virology (2008) 0.83
HIV-1 ribonuclease H inhibitory phenolic glycosides from Eugenia hyemalis. J Nat Prod (2008) 0.82
Exploiting structurally diverse nucleoside analogs as probes of reverse transcription complexes. Curr HIV Res (2007) 0.82
Probing anomalous structural features in polypurine tract-containing RNA-DNA hybrids with neomycin B. Biochemistry (2009) 0.82
Slow tight binding inhibition of proteinase K by a proteinaceous inhibitor: conformational alterations responsible for conferring irreversibility to the enzyme-inhibitor complex. J Biol Chem (2003) 0.82
Identification of biologically active, HIV TAR RNA-binding small molecules using small molecule microarrays. J Am Chem Soc (2014) 0.81
DNA aptamers to human immunodeficiency virus reverse transcriptase selected by a primer-free SELEX method: characterization and comparison with other aptamers. Nucleic Acid Ther (2012) 0.81
Investigating the "steric gate" of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase by targeted insertion of unnatural amino acids. Biochemistry (2007) 0.81
Examining Ty3 polypurine tract structure and function by nucleoside analog interference. J Biol Chem (2005) 0.81
Functional roles of carboxylate residues comprising the DNA polymerase active site triad of Ty3 reverse transcriptase. Nucleic Acids Res (2005) 0.81
Site- and subunit-specific incorporation of unnatural amino acids into HIV-1 reverse transcriptase. Protein Expr Purif (2004) 0.80
Downregulation of APOBEC3G by xenotropic murine leukemia-virus related virus (XMRV) in prostate cancer cells. Virol J (2011) 0.80
Basic quinolinonyl diketo acid derivatives as inhibitors of HIV integrase and their activity against RNase H function of reverse transcriptase. J Med Chem (2014) 0.80
Interaction of the Ty3 reverse transcriptase thumb subdomain with template-primer. J Biol Chem (2005) 0.80
Probing Retroviral and Retrotransposon Genome Structures: The "SHAPE" of Things to Come. Mol Biol Int (2012) 0.80
Exploiting drug-resistant enzymes as tools to identify thienopyrimidinone inhibitors of human immunodeficiency virus reverse transcriptase-associated ribonuclease H. J Med Chem (2013) 0.80
Revisiting plus-strand DNA synthesis in retroviruses and long terminal repeat retrotransposons: dynamics of enzyme: substrate interactions. Viruses (2009) 0.80
Synthetic tRNALys,3 as the replication primer for the HIV-1HXB2 and HIV-1Mal genomes. Nucleic Acids Res (2004) 0.79
Influence of RNA structural elements on Ty1 retrotransposition. Mob Genet Elements (2013) 0.79
Duplex structural differences and not 2'-hydroxyls explain the more stable binding of HIV-reverse transcriptase to RNA-DNA versus DNA-DNA. Nucleic Acids Res (2010) 0.79
Solid-Phase Synthesis of 5'-O-β,γ-Methylenetriphosphate Derivatives of Nucleosides and Evaluation of Their Inhibitory Activity Against HIV-1 Reverse Transcriptase. Tetrahedron Lett (2010) 0.79
Interaction of HIV reverse transcriptase with structures mimicking recombination intermediates. J Biol Chem (2003) 0.79
A prospective on drug abuse-associated epigenetics and HIV-1 replication. Life Sci (2010) 0.78
RNA secondary structure prediction using high-throughput SHAPE. J Vis Exp (2013) 0.77
The Complex Interaction Between Methamphetamine Abuse and HIV-1 Pathogenesis. J Neuroimmune Pharmacol (2015) 0.77